Attenuation of oxidative stress-induced vascular endothelial dysfunction by thymoquinone

被引:28
作者
El-Agamy, Dina S. [1 ]
Nader, Manar A. [1 ]
机构
[1] Mansoura Univ, Fac Pharm, Dept Pharmacol & Toxicol, Mansoura 35516, Egypt
关键词
thymoquinone; aorta; oxidative stress; pyrogallol; rabbits; NITRIC-OXIDE SYNTHASE; NIGELLA-SATIVA; SUPEROXIDE ANION; RELAXATION; MECHANISM; PROTECTS; MICE; TISSUES; SYSTEM; ASSAY;
D O I
10.1258/ebm.2012.012107
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
100103 [病原生物学]; 100218 [急诊医学];
摘要
This study aimed to assess the effects of thymoquinone (TQ) on pyrogallol-induced endothelial dysfunction in isolated rabbit aorta. The protective effects of TQ were examined by incubating aortic rings in TQ concomitant with pyrogallol. The results revealed that pyrogallol produced significant enhancement of phenylephrine-induced contraction and impairment of acetylcholine-induced relaxation. Pyrogallol caused a significant increase in lipid peroxidation and reduction in the level of superoxide dismutase and reduced glutathione in the aortic homogenates. In addition, pyrogallol produced a significant decrease in nitrite/nitrate concentrations (NOx), constitutive nitric oxide synthase (cNOS) activity and an increase in inducible nitric oxide synthase (iNOS) activity in the aortic homogenates. These changes were counteracted by TQ co-incubation as TQ attenuated pyrogallol-induced impairment in vascular reactivity in a dose-dependent manner. Furthermore, TQ showed potent antioxidant activity as well as causing a significant increase in NOx and cNOS activity, and depression in iNOS activity. These results suggest that TO can protect against pyrogallol-induced endothelial dysfunction which probably results from its potent antioxidant capacity that leads to an increase in NO production as well as its ability to enhance the generation and bioavailability of NO.
引用
收藏
页码:1032 / 1038
页数:7
相关论文
共 44 条
[1]
Neuroprotective effects of thymoquinone against transient forebrain ischemia in the rat hippocampus [J].
Al-Majed, Abdulhakeem A. ;
Al-Omar, Fadhel A. ;
Nagi, Mahmoud N. .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2006, 543 (1-3) :40-47
[2]
Al-Shabanah OA, 1998, J EXP CLIN CANC RES, V17, P193
[3]
Alya Mutabagani Alya Mutabagani, 1997, Saudi Pharmaceutical Journal, V5, P110
[4]
Thymoquinone ameliorates the nephrotoxicity induced by cisplatin in rodents and potentiates its antitumor activity [J].
Badary, OA ;
Nagi, MN ;
Al-Shabanah, OA ;
Al-Sawaf, HA ;
Al-Sohaibani, MO ;
Al-Bekairi, AM .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1997, 75 (12) :1356-1361
[5]
Thymoquinone is a potent superoxide anion scavenger [J].
Badary, OA ;
Taha, RA ;
El-Din, AMG ;
Abdel-Wahab, MH .
DRUG AND CHEMICAL TOXICOLOGY, 2003, 26 (02) :87-98
[6]
Pharmacological interventions to prevent vascular endothelial dysfunction: Future directions [J].
Balakumar, Pitchai ;
Koladiya, Rajeshkumar U. ;
Ramasamy, Subbiah ;
Rathinavel, Andiappan ;
Singh, Manjeet .
JOURNAL OF HEALTH SCIENCE, 2008, 54 (01) :1-16
[7]
Benfotiamine attenuates nicotine and uric acid-induced vascular endothelial dysfunction in the rat [J].
Balakumar, Pitchai ;
Sharma, Ramica ;
Singh, Manjeet .
PHARMACOLOGICAL RESEARCH, 2008, 58 (5-6) :356-363
[8]
O2--mediated impairment of coronary arterial relaxation is prevented by overnight treatment with 1 nM β-estradiol [J].
Bell, DR ;
Gochenaur, KE ;
Hecht, J .
JOURNAL OF APPLIED PHYSIOLOGY, 2002, 93 (06) :1952-1958
[9]
Endothelial dysfunction - A marker of atherosclerotic risk [J].
Bonetti, PO ;
Lerman, LO ;
Lerman, A .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (02) :168-175
[10]
Endothelial dysfunction in cardiovascular diseases - The role of oxidant stress [J].
Cai, H ;
Harrison, DG .
CIRCULATION RESEARCH, 2000, 87 (10) :840-844